Dynavax Technologies | 销售和管理费用

Selling And Administration Expenses 更改 日
Adma Biologics USD 16.22M 1.03M 2023-12
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Dynavax Technologies USD 39.79M 2.63M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
TG Therapeutics USD 31.15M 1.62M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Dynavax Technologies 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.